Filing Details
- Accession Number:
- 0001437749-23-002336
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-02 13:02:20
- Reporting Period:
- 2023-01-31
- Accepted Time:
- 2023-02-02 13:02:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763581 | Mark Schoenberg | 400 Alexander Park Drive Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2023-01-31 | 500 | $0.00 | 147,127 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-01-31 | 248 | $10.12 | 146,879 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-01-31 | 2,000 | $0.00 | 148,879 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-01-31 | 991 | $10.12 | 147,888 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-01-31 | 1,333 | $0.00 | 149,221 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-01-31 | 661 | $10.12 | 148,560 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2023-01-31 | 500 | $0.00 | 500 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2023-01-31 | 2,000 | $0.00 | 2,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2023-01-31 | 1,333 | $0.00 | 1,333 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Acquisiton | 2023-01-31 | 10,000 | $0.00 | 10,000 | $0.00 |
| Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2023-01-31 | 30,000 | $0.00 | 30,000 | $10.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 2,000 | No | 4 | M | Direct | ||
| 2,667 | No | 4 | M | Direct | ||
| 10,000 | No | 4 | A | Direct | ||
| 30,000 | 2033-01-31 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter.
- The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022.
- The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
- 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
- 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
- Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
Billionaire Hedge Funds
